The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.

NCT07067710 | Recruiting

• 2 other identifiers: PI_2023/81 Programa IM-OA23PI_2023/81
• Study Type: interventional
• Target: 108
• Locations: 1 country
• Sites: 3

Brief Summary

The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.

Conditions

Breast Cancer Survivor

Keywords

Motor imagery; Action observation

Outcome Measures

Primary Outcomes (6)

• Sthrength

  The grip strength of the hand of the affected limb shall be studied, using a dynamometer.

  From enrollement to the end of the treatment at 6 weeks and 3 month after

• Range of Motion

  The measurement of the degrees of movement of the shoulder joint by means of a goniometer. The movements of flexion, abduction and internal and external rotation shall be studied using previously established reference points. external rotation, using previously established reference points

  From enrollement to the end of the treatment at 6 weeks and 3 month after

• Pain intensity

  Pain intensity will be measured by Visual Analogue Scale (VAS). Participants will have to score their pain on a range from 0 to 10 where 0 means "no pain at all" and 10 "my pain is as bas as it could possibly be".

  From enrollement to the end of the treatment at 6 weeks and 3 month after

• Limb diameter

  Limb diameter will be measured by a measuring tape. The measurement is taken at the midpoint between the acromion and the olecranon, the tape being perpendicular to the limb without compressing the area. The midpoint is located with an elbow flexion of 90 degrees and then the measurement is taken with the elbow in extension, the result is expressed in centimetres.

  From enrollement to the end of the treatment at 6 weeks and 3 month after

• Fear of movement

  Fear of movement will be measured by the TSK questionnaire

  From enrollement to the end of the treatment at 6 weeks and 3 month after

• Imagery

  Imagery will be assessed using the Movement Imagery Questionnaire revised second edition (MIQ-RS)

  From enrollement to the end of the treatment at 6 weeks and 3 month after

Study Arms (2)

IMOA group

EXPERIMENTAL

The intervention group will participate in the IM-OA23 programme; the combination of motor imagery and action observation therapies.

Other: Motor imagery combined with action observation

Control group

NO INTERVENTION

The control group will follow the usual care from primary care. There are no care programmes for long term cancer survivors.

Interventions

Motor imagery combined with action observation OTHER

To observe and imaging one action with a video resource. Not virtual reality.

IMOA group

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Female, over 18 years, have suffered breast cancer, have ended active treatments (chemotherapy, radiotherapy, surgery), have pain or functional limitation or lymphedema at upper limb afected.

You may not qualify if:

• males, people with active treatments ongoning, other types of cancer, recurrence or metastasis of cancer

Sponsors & Collaborators

• Fundacion Miguel Servet: lead
• Instituto de Investigación Sanitaria de Navarra (IdiSNA): collaborator

Study Sites (3)

Public University of Navarre

Pamplona, Navarre, 31008, Spain

NOT YET RECRUITING

Public University of Navarre

Pamplona, Navarre, 31008, Spain

RECRUITING

Public University of Navarre

Pamplona, Navarre, 31008, Spain

RECRUITING

Study Officials

• Paula Escalada-Hernández, PhD

  Public University of Navarra

  STUDY DIRECTOR

• Nelia Soto-Ruiz, PhD

  Universidad Pública de Navarra

  STUDY DIRECTOR

• Pilar Arnal-Vallés, Candidate PhD

  Hospital of Navarra

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Pilar Arnal-Vallés, Candidate PhD

CONTACT

+34 948166117; pilararnal3b@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 9, 2025
• First Posted: July 16, 2025
• Study Start: February 25, 2025
• Primary Completion: April 28, 2025
• Study Completion: February 1, 2026
• Last Updated: July 16, 2025

Record last verified: 2025-07

Locations

ES (3)